CBC Group sets up AffaMed, EverInsight merger, eyes IPO

Complementing Your Psychotherapy

Benzodiazepines Hit With Boxed Warning by FDA

CBC-funded Affamed merges with Everinsight, extends portfolio with Kissei PD candidate

Michael Liebowitz, MD, VistaGen CNS Clinical and Regulatory Advisory Board Member and Pivotal Phase 3 Principal Investigator: The Mental Health Impact of COVID-19

The Future of Anxiety Treatment Will Be Drastically Different

Pushing Late-Stage Treatments Forward in the Clinic

Treating social anxiety disorder: VistaGen and EverInsight collaborate in Asian markets

VistaGen out-licenses rights to anxiety disorder candidate in Asia territories